• Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Theranica Named to Fast Company's Annual List of the World's Most Innovative Companies for 2020

Developer of Nerivio™, a Drug-Free Therapeutic Wearable for the Acute Treatment of Migraine, Recognized as a Leading Biotech Innovator


News provided by

Theranica

10 Mar, 2020, 15:00 IST

Share this article

Share this article


NETANYA, Israel, March 10, 2020 /PRNewswire/ -- Theranica Bioelectronics (Theranica), a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today that it has been ranked fourth in Fast Company's Biotech category on the 2020 Most Innovative Companies List. The prestigious annual list identifies companies making the most profound impact on their industry.

"We are honored to be recognized by Fast Company and to be listed alongside innovative companies that are making a difference in people's lives," said Alon Iron, CEO and co-founder of Theranica. "We are proud of our contribution to advancing drug-free pain management with the creation of Nerivio™, a migraine wearable treatment device that provides patients with an alternative and effective solution to current pharma options."

The World's Most Innovative Companies is Fast Company's signature program and one of its most highly anticipated editorial efforts of the year. It provides a comprehensive overview of innovation happening throughout countless industries that are collectively striving to improve the world. Fast Company sought the most groundbreaking businesses worldwide across a myriad of industries, and judged nominations received through their application process.

"We are proud of the work that Theranica has been conducting to bring Nerivio to market and making it accessible to migraine sufferers," said Todd Sone, Partner at aMoon Fund. "Patients now have access to a true ergonomic, non-pharmacologic personalized therapy with excellent clinical results."

Nerivio™ is the first smartphone-controlled wearable device for the acute treatment of migraine. Placed on the upper arm, it uses electronic pulses to remotely stimulate a Conditioned Pain Modulation response to mitigate pain and abort a migraine with minimal side effects. Nerivio received De Novo approval to market from the U.S. Food and Drug Administration (FDA) in May 2019. The prescription device can be filled through Quick Care Pharmacy or through telemedicine platform Cove.

This recognition follows two recent awards. Nerivio was included in TIME Magazine's List of 100 Best Inventions of 2019, and Theranica was named an industry 'Game Changer' by CB Insights.

About Theranica

Theranica Bio-Electronics, founded in 2016, is dedicated to combining advanced neuromodulation therapy with modern wireless technology to develop proprietary electroceuticals that address prevalent medical conditions and diseases. Nerivio™, Theranica's first FDA authorized to market device, is a wearable for acute treatment of migraine. Theranica will continue to use its proprietary technology to develop additional solutions to other pain disorders.

Learn more by visiting the website, http://theranica.com.
Follow Theranica on LinkedIn and Twitter.

Theranica Media Contact:
Ellie Hanson
Finn Partners
[email protected]
+1 929-222-8006

Theranica Contact:
Ronen Jashek
[email protected]
+972-72-390-9750

SOURCE Theranica

Related Links

http://theranica.com/

Modal title

Also from this source

Pennsylvania-based Highmark Inc. Joins Theranica's Coverage with Evidence Program for Nerivio® Drug-Free Migraine Treatment Device

Explore

More news releases in similar topics

  • Health Care & Hospitals
  • Medical Pharmaceuticals
  • Medical Equipment
  • Publishing & Information Services
  • Consumer Electronics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2022 Cision US Inc.